Flow Cytometry for Diagnosis and Assessment of Prognosis in Patients with Myelodysplastic Syndromes

References

• Greenberg, P.L. (2000) "Myelodysplastic syndrome", In: Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E. and McGlave, P., eds, Hematology: Basic Principles and Practice, 3rd Ed. (Churchill Livingstone, New York), pp 1106–1129.
   Google Scholar
• Benesch, M. and Deeg, H.J. (2003) "Hemopoietic cell transplantation for myelodysplastic syndromes", Curr. Hematol. Rep. 2, 209–216.
   PubMedGoogle Scholar
• Loken, M.R. and Wells, D.A. (2000) "Normal antigen expression in hematopoiesis: basis for interpreting leukemia phenotypes", In: Stewart, C.C. and Nicholson, J.K.A., eds, Normal Antigen Expression in Hematopoiesis: Basis for Interpreting Leukemia Phenotypes (Wiley-Liss, New York, NY), pp 133–160.
   Google Scholar
• Owens, M.A. and Loken, M.R. (1995) Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitative Immunophenotyping (Wiley-Liss, New York, NY).
   Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., Sultan, C. and The French-American—British (FAB) Co-Operative Group (1982) "Propo-sals for the classification of the myelodysplastic syndromes", Br. J. Haematol. 51, 189–199.
   PubMed Web of Science ®Google Scholar
• Sanz, G.F., Sanz, M.A., Vallespi, T., Caftizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. and San Miguel, J.F. (1989) "Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients", Blood 74, 395–408.
   PubMed Web of Science ®Google Scholar
• Toyama, K., Ohyashiki, K., Yoshida, Y, et al. (1993) "Clinical implications of chromosomal abnormalities in 401 patients with MDS: a mulicentric study in Japan", Leukemia 7, 499–508.
   PubMed Web of Science ®Google Scholar
• Coiffier, B., Adeleine, P., Gentilhomme, O., Felman, P., Treille-Ritouet, D. and Bryon, P.A. (1987) "Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients", Cancer 60, 3029–3032.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, ES., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting—Airlie House, Virginia, November 1997", J. Clin. Oncol. 17,3835–3849.
   PubMed Web of Science ®Google Scholar
• Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. and Bennett, J. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes (published erratum appears in Blood 1998; 91, 1100)", Blood 89, 2079–2088.
   PubMed Web of Science ®Google Scholar
• Appelbaum, F.R. and Anderson, J. (1998) "Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score", Leukemia 12\(Suppl. 1), S25—S29.
   PubMedGoogle Scholar
• Deeg, H.J., Storer, B., Slattery, J.T., Anasetti, C., Doney, K.C., Hansen, J.A., Kiem, H.-P., Martin, P.J., Petersdorf, E., Radich, J.P., Sanders, J.E., Shulman, H.M., Warren, E.H., Witherspoon, R.P., Bryant, E.M., Chauncey, T.R., Getzendaner, L., Storb, R. and Appelbaum, ER. (2002) "Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome", Blood 100, 1201–1207.
   PubMed Web of Science ®Google Scholar
• Griffin, J.D., Davis, R., Nelson, D.A., Davey, ER., Mayer, R.J., Schiffer, C., McIntyre, O.R. and Bloomfield, C.D. (1986) "Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia", Blood 68, 1232–1241.
   PubMed Web of Science ®Google Scholar
• Borowitz, M.J., Guenther, K.L., Shults, K.E. and Stelzer, G.T. (1993) "Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis", Am. J. Clin. Pathol. 100, 534–540.
   PubMed Web of Science ®Google Scholar
• Reading, C.L., Estey, E.H., Huh, Y.O., Claxton, D.F., Sanchez, G., Terstappen, L.W., O'Brien, M.C., Baron, S. and Deisseroth, A.B. (1993) "Expression of unusual immunophenotype combina-tions in acute myelogenous leukemia", Blood 81,3083–3090.
   PubMed Web of Science ®Google Scholar
• Wells, D.A., Hall, M.C., Shulman, H.M. and Loken, M.R. (1998) "Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias", Leukemia 12, 2015–2023.
   PubMed Web of Science ®Google Scholar
• Sievers, E.L., Lange, B.J., Alonzo, T.A., Gerbing, R.B., Bernstein, ID., Smith, F.O., Arceci, R.J., Woods, W.G. and Loken, M.R. (2003) "Immunophenotypic evidence of leuke-mia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia", Blood 101, 3398–3406.
   PubMed Web of Science ®Google Scholar
• Terstappen, L.W., Safford, M. and Loken, M.R. (1990) "Flow cytometric analysis of human bone marrow. DI Neutrophil maturation", Leukemia 4, 657–663.
   PubMed Web of Science ®Google Scholar
• Terstappen, L.W., Konemarm, S., Safford, M., Loken, M.R., Zurlutter, K., Buchner, T., Hiddemann, W. and Wormann, B. (1991) "Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties", Leukemia 5, 315–321.
   PubMed Web of Science ®Google Scholar
• Terstappen, L.W., Safford, M., Konemann, S., Loken, M.R., Zurlutter, K., Buchner, T., Hiddemann, W. and Wormann, B. (1992) "Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis", Leukemia 6, 70–80.
   PubMed Web of Science ®Google Scholar
• Elghetany, M.T. (1998) "Surface marker abnormalities in myelodysplastic syndromes (Review)", Haematologica 83, 1104–1115.
   PubMed Web of Science ®Google Scholar
• Karmon, Y., Manaster, J. and Chezar, J. (2002) "Immuno-phenotypic characterization of myelopoiesis in early and late myelodysplastic syndromes: use of CD44 as an aid in early diagnosis", Cytometry 50, 225–230.
   PubMedGoogle Scholar
• Jilani, I., Estey, E., Huh, Y, Joe, Y., Manshouri, T., Yared, M., Giles, F., Kantarjian, H., Cortes, J., Thomas, D., Keating, M., Freireich, E. and Albitar, M. (2002) "Differences in CD33 intensity between various myeloid neoplasms", Am. J. Clin. Pathol. 118, 560–566.
   PubMed Web of Science ®Google Scholar
• Maynadie, M., Picard, F., Husson, B., Chatelain, B., Cornet, Y, Le Roux, G., Campos, L., Dromelet, A., Lepelley, P., Jouault, H., Imbert, M., Rosenwadj, M., Verge, V, Bissieres, P, Raphael, M., Bene, MC., Feuillard, J. and The Groupe d'Etude Immunologique des Leucemies (2002) "Immuno-phenotypic clustering of myelodysplastic syndromes", Blood 100, 2349–2356.
   PubMed Web of Science ®Google Scholar
• Sultana, TA., Harada, H., Ito, K., Tanaka, H., Kyo, T. and Kimura, A. (2003) "Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34+ + cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia", Br. J. Haematol. 121, 63–75.
   PubMed Web of Science ®Google Scholar
• Inaba, T., Shimazaki, C., Sumikuma, T., Shimura, K., Takahashi, R., Hirai, H., Ashihara, E., Sudo, Y, Murakami, S., Haruyama, H., Fujita, N., Yoshimura, M. and Nakagawa, M. (1998) "Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome", Int. J. Hematol. 68, 403–410.
   PubMed Web of Science ®Google Scholar
• Fuchigami, K., Mori, H., Matsuo, T., Iwanaga, M., Nagai, K., Kuriyama, K. and Tomonaga, M. (2000) "Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry", Leuk. Res. 24, 163–174.
   PubMed Web of Science ®Google Scholar
• Kyriakou, D.S., Alexandrakis, M., Tzardi, M., Stephanaki, D. and Eliopoulos, G.D. (2000) "Downregulation of CD43 in RAEB and RAEB-T patients. Report of 3 cases", Am. J. Hematol. 63, 20–27.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson, M., Arthur, D.C., Jabbour, N., Xie, X.Y., Molldrem, J., Barrett, A.J., Venzon, D. and Rick, M.E. (2001) "Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome", Blood 98, 979–987.
   PubMed Web of Science ®Google Scholar
• Ogata, K., Nakamura, K., Yokose, N., Tamura, H., Tachibana, M., Taniguchi, O., Iwakiri, R., Hayashi, T., Sakamaki, H., Murai, Y, Tohyama, K., Tomoyasu, S., Nonaka, Y, Mori, M., Dan, K. and Yoshida, Y. (2002) "Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome", Blood 100, 3887–3896.
   PubMed Web of Science ®Google Scholar
• Ito, S., Ishida, Y., Murai, K. and Kuriya, S. (2001) "Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome", Leuk. Res. 25, 205–211.
   PubMed Web of Science ®Google Scholar
• Wells, D.A., Benesch, M., Loken, M.R., Vallejo, C., Myerson, D., Leisenring, W.M. and Deeg, H.J. (2003) "Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hemopoietic stem cell transplantation", Blood 102, 394–403.
   PubMed Web of Science ®Google Scholar
• Kasahara, S., Hara, T., Itoh, H., Ando, K., Tsurumi, H., Sawada, M., Yamada, T., Ohnishi, H. and Moriwaki, H. (2002) "Hypoplastic myelodysplastic syndromes can be dis-tinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor", Br. J. Haematol. 118, 181–188.
   PubMed Web of Science ®Google Scholar